Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on May 22, 2025

AMBCI Medical Billing and Coding Certification Achieves Prestigious CPD Accreditation
AMBCI announces the accreditation of our multi-specialty Medical Billing and Coding Certification by the Continuing Professional Development (CPD) organization. OREM, UT, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- The Advanced Medical Billing and …

Global High-Throughput Screening Market Poised for Strong Growth, Hitting $39.2 Billion by 2029
Boston, May 22, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “High-Throughput Screening: Technologies and Global Markets” is expected to grow from $23.8 billion in 2024 to $39.2 billion by the end of 2029 at a compound annual …

NeurAxis Announces Closing of $5.0 Million Registered Direct Offering
CARMEL, Ind., May 22, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults …

Bio Usawa and Pacific Environmental Technologies Announce Landmark Partnership to Develop and Deploy Modular cGMP Biomanufacturing Units for Africa
SAN FRANCISCO and KIGALI, Rwanda, May 22, 2025 (GLOBE NEWSWIRE) -- Bio Usawa, Inc., a biopharmaceutical company based in San Francisco, Kigali, and Nairobi, committed to expanding access to life-saving biologics in Africa and underserved regions, today …

Legend Senior Living’s Workplace Culture Earns Seventh Great Place to Work® Certification
WICHITA, Kan., May 22, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living® has earned its seventh consecutive Great Place to Work® certification, a distinction based on results from an annual, anonymous employee survey conducted by the independent research firm …

Simple Avo™ Named “Best Virtual Health Coach” in 2025 MedTech Breakthrough Awards Program
LOS ANGELES, May 22, 2025 (GLOBE NEWSWIRE) -- MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market, today announced …

Total Ancillary Joins Forces with WoundGenex
DALLAS, May 22, 2025 (GLOBE NEWSWIRE) -- Providers now will have access to additional support services, thanks to an alliance between leading wound care solutions provider Total Ancillary and WoundGenex, a trusted name in wound care associated …

Wandercraft Celebrates Opening of “Walk in New York” to Restore Upright Mobility for People with Mobility Disabilities
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Wandercraft, a global leader in robotic mobility solutions as the AI-powered Personal Exoskeleton, officially opened its doors today to Walk in New York by Wandercraft, a first-of-its-kind private practice …

Dandy Launches Real-Time Video Collaboration for Dentists and Lab Techs
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Dandy, the fully digital dental lab, today launched a new suite of real-time visual collaboration features for its pioneering Chairside and case management software for dental practices. Dentists and lab techs can …

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market
NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 22, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a dynamic, multi-asset clinical stage, life science company delivering an efficient model for compound …

Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing
INBS to participate with U.S. distribution partner SMARTOX at RISE25, the leading U.S. conference on addiction, mental health, and justice innovation which draws over 7,000 attendees annually With over 450 active accounts across 24 countries, INBS …

Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System
Real-World Impact: Initial data from over 360 patients shows inFoods® IBS delivered an average 48.5% reduction in gastrointestinal pain and a 49.8% reduction in bloating over an 8-week period First-of-Its-Kind inFoods® IBS Feedback Platform: New real-time …

NorthStrive Biosciences Announces Completion of Phase I Strategic Review for EL-22 Targeting Muscle Loss Associated with GLP-1 Weight Loss Drugs and Age-Related Sarcopenia
NEWPORT BEACH, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Northstrive Biosciences Inc. (“Northstrive”), a subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB) (the “Company,” “PMGC,” “we,” or “our”), today announced the completion of a Phase I strategic research …

AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition
PITTSBURGH, May 22, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) moves to leverage its vast biobank of more than 150,000 heterogenous live cell tumor samples and drug response data to aggressively pursue novel drug discovery, biomarker …

LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy®
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced a limited-time $299 introductory bundle for new self-pay patients prescribed Wegovy® (semaglutide), which includes …

SCIENTURE Announces Executive Leadership Transition
TAMPA, FL, May 22, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers …

Avalyn to Participate in the Jefferies Global Healthcare Conference in June
CAMBRIDGE, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company developing inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced that management will participate in the …

GRI Bio Presents Positive Pre-Clinical Data Demonstrating GRI-0621 Resolves Inflammation and Fibrosis in Bleomycin-Induced Fibrosis and Reiterates Promising Preliminary Phase 2a Clinical Results
Data presented at the 2025 American Thoracic Society (ATS) International Conference Pre-clinical and interim clinical results underscore GRI-0621’s potential to have both anti-inflammatory and anti-fibrotic effects in pulmonary fibrosis Results from 6-week …

Sequel Med Tech to Integrate twiist Automated Insulin Delivery (AID) System with Abbott’s Future Dual Glucose-Ketone Sensor
MANCHESTER, N.H., May 22, 2025 (GLOBE NEWSWIRE) -- Sequel Med Tech, LLC, a company developing state-of-the-art insulin delivery technologies today announced a commercial development agreement for future integration of Sequel’s twiist™ Automated Insulin …

Petvivo Holdings, Inc. and PiezoBioMembrane Inc. Announce Master Services Agreement to Jointly Develop Innovative Functional Biomaterials
MINNEAPOLIS, May 22, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively referred to herein as the "Company" or “PetVivo”) an emerging biomedical device …